Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
15.99
-1.64 (-9.30%)
At close: Oct 1, 2026, 4:00 PM EDT
16.03
+0.04 (0.25%)
After-hours: Oct 1, 2026, 7:30 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $168.64 million as of October 1, 2026. Its market cap has increased by 81.07% in one year.
Market Cap
168.64M
Enterprise Value
113.92M
1-Year Change
81.07%
Ranking
Category
Stock Price
$15.99
ChartMarket Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $168.64M, a decrease of -93.27%. That is a compound annual growth rate of -34.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 168.64M | -22.27% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.71B |
| OPKO Health | 1.21B |
| Castle Biosciences | 1.07B |
| Fulgent Genetics | 607.54M |
| Myriad Genetics | 404.60M |
| Biodesix | 307.46M |
| Exagen | 201.07M |
| Insight Molecular Diagnostics | 110.61M |